Literature DB >> 18184082

Failure of TLR4-driven NF-kappa B activation to stimulate virus replication in models of HIV type 1 activation.

Sushila K Nordone1, Glicerio A Ignacio, Lishan Su, Gregory D Sempowski, Douglas T Golenbock, Liwu Li, Gregg A Dean.   

Abstract

The interaction of HIV-1 with Toll-like receptors (TLR) on host target cells is incompletely understood. Data from several in vivo and in vitro model systems suggest that TLR2, TLR4, and TLR9 remain functional and if stimulated, cause an upregulation of viral replication. In the present studies employing two different chronically HIV-1-infected cell lines and highly purified TLR agonists, we found ligation of TLR2 and TLR9, but not TLR4, resulted in significant upregulation of HIV-1 production. This result was not due to a lack of TLR4 expression or impaired NF-kappa B activation. Using HEK293 cells transfected with individual TLRs and an HIV-1 LTR reporter confirmed that TLR4 signaling does not directly activate the HIV-1 LTR. Finally, ultrapurified LPS did not enhance production of IL-1 beta or IL-6 in chronically infected U1 cells, whereas significant cytokine production was observed in uninfected U937 cells. These results confirm the biological activity of ultrapurified LPS and raise the possibility that TLR4 signaling pathways may be altered during chronic HIV-1 infection. Collectively, these studies suggest that although several TLR can upregulate NF-kappaB in HIV-1-infected cells, upregulation of NF-kappaB alone is insufficient to activate the viral LTR. Further dissection of the TLR signaling pathways is necessary to determine how TLR stimulation leads to LTR activation and whether HIV-1 infection can alter signaling through TLR4.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18184082      PMCID: PMC4415363          DOI: 10.1089/aid.2007.0033

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  42 in total

Review 1.  Hostile takeovers: viral appropriation of the NF-kappaB pathway.

Authors:  J Hiscott; H Kwon; P Génin
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

2.  Characterization of a promonocyte clone chronically infected with HIV and inducible by 13-phorbol-12-myristate acetate.

Authors:  T M Folks; J Justement; A Kinter; S Schnittman; J Orenstein; G Poli; A S Fauci
Journal:  J Immunol       Date:  1988-02-15       Impact factor: 5.422

3.  Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines.

Authors:  Kol A Zarember; Paul J Godowski
Journal:  J Immunol       Date:  2002-01-15       Impact factor: 5.422

4.  Direct stimulation of human T cells via TLR5 and TLR7/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells.

Authors:  Gersende Caron; Dorothée Duluc; Isabelle Frémaux; Pascale Jeannin; Catherine David; Hugues Gascan; Yves Delneste
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

5.  Human immunodeficiency virus type 1 protease inhibitors block toll-like receptor 2 (TLR2)- and TLR4-Induced NF-kappaB activation.

Authors:  Ozlem Equils; Alan Shapiro; Zeynep Madak; Chunren Liu; Daning Lu
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

6.  Bacterial lipopolysaccharide activates HIV long terminal repeat through Toll-like receptor 4.

Authors:  O Equils; E Faure; L Thomas; Y Bulut; S Trushin; M Arditi
Journal:  J Immunol       Date:  2001-02-15       Impact factor: 5.422

7.  Cutting edge: in vivo induction of integrated HIV-1 expression by mycobacteria is critically dependent on Toll-like receptor 2.

Authors:  André Báfica; Charles A Scanga; Marco L Schito; Sara Hieny; Alan Sher
Journal:  J Immunol       Date:  2003-08-01       Impact factor: 5.422

8.  Stimulation of toll-like receptor 2 in mononuclear cells from HIV-infected patients induces chemokine responses: possible pathogenic consequences.

Authors:  L Heggelund; J K Damås; A Yndestad; A M Holm; F Mūller; E Lien; T Espevik; P Aukrust; S S Frøland
Journal:  Clin Exp Immunol       Date:  2004-10       Impact factor: 4.330

9.  Processing and secretion of tumor necrosis factor alpha in endotoxin-treated Mono Mac 6 cells are dependent on phorbol myristate acetate.

Authors:  A Pradines-Figueres; C R Raetz
Journal:  J Biol Chem       Date:  1992-11-15       Impact factor: 5.157

10.  Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.

Authors:  T A Lodie; M Reiner; S Coniglio; G Viglianti; M J Fenton
Journal:  J Immunol       Date:  1998-07-01       Impact factor: 5.422

View more
  17 in total

1.  HIV type 1 infection up-regulates TLR2 and TLR4 expression and function in vivo and in vitro.

Authors:  Juan C Hernández; Mario Stevenson; Eicke Latz; Silvio Urcuqui-Inchima
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-12       Impact factor: 2.205

2.  Supernatants from oral epithelial cells and gingival fibroblasts modulate human immunodeficiency virus type 1 promoter activation induced by periodontopathogens in monocytes/macrophages.

Authors:  O A González; J L Ebersole; C B Huang
Journal:  Mol Oral Microbiol       Date:  2010-04       Impact factor: 3.563

Review 3.  Immune activation and the role of TLRs and TLR agonists in the pathogenesis of HIV-1 infection in the humanized mouse model.

Authors:  J Judy Chang; Marcus Altfeld
Journal:  J Infect Dis       Date:  2013-11       Impact factor: 5.226

4.  HIV-1 reactivation induced by the periodontal pathogens Fusobacterium nucleatum and Porphyromonas gingivalis involves Toll-like receptor 2 [corrected] and 9 activation in monocytes/macrophages.

Authors:  Octavio A González; Mengtao Li; Jeffrey L Ebersole; Chifu B Huang
Journal:  Clin Vaccine Immunol       Date:  2010-07-07

5.  The oral commensal, Streptococcus gordonii, synergizes with Tat protein to induce HIV-1 promoter activation in monocytes/macrophages.

Authors:  Octavio A González; Jeffrey L Ebersole; Chifu B Huang
Journal:  Cell Immunol       Date:  2011-03-15       Impact factor: 4.868

6.  Nuclear receptor signaling inhibits HIV-1 replication in macrophages through multiple trans-repression mechanisms.

Authors:  Timothy M Hanley; Gregory A Viglianti
Journal:  J Virol       Date:  2011-08-17       Impact factor: 5.103

7.  MyD88-dependent TLR4 signaling is selectively impaired in alveolar macrophages from asymptomatic HIV+ persons.

Authors:  Souvenir D Tachado; Xin Li; Medhavi Bole; Katharine Swan; Asha Anandaiah; Naimish R Patel; Henry Koziel
Journal:  Blood       Date:  2010-03-02       Impact factor: 22.113

8.  A myristoylated alanine-rich C kinase substrate-related peptide suppresses cytokine mRNA and protein expression in LPS-activated canine neutrophils.

Authors:  Jingjing Li; Melissa A D'Annibale-Tolhurst; Kenneth B Adler; Shijing Fang; Qui Yin; Adam J Birkenheuer; Michael G Levy; Samuel L Jones; Eui Jae Sung; Eleanor C Hawkins; Jeffrey A Yoder; Shila K Nordone
Journal:  Am J Respir Cell Mol Biol       Date:  2012-12-06       Impact factor: 6.914

9.  Human immunodeficiency virus infection alters tumor necrosis factor alpha production via Toll-like receptor-dependent pathways in alveolar macrophages and U1 cells.

Authors:  Marlynne Q Nicol; Jean-Marie Mathys; Albertina Pereira; Kevin Ollington; Michael H Ieong; Paul R Skolnik
Journal:  J Virol       Date:  2008-06-04       Impact factor: 5.103

Review 10.  Oral infectious diseases: a potential risk factor for HIV virus recrudescence?

Authors:  O A González; J L Ebersole; C B Huang
Journal:  Oral Dis       Date:  2009-04-02       Impact factor: 3.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.